[1]Isakoff MS,Bielack SS,Meltzer P,et al.Osteosarcoma: Current Treatment and a Collaborative Pathway to Success[J].J Clin Oncol,2015,33(27):3029-3035. [2]Kempf-Bielack B,Bielack SS,Jurgens H,et al.Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)[J].J Clin Oncol,2005,23(3):559-568. [3]Liu K,He Q,Liao G,et al.Identification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs[J].Exp Ther Med,2015,10(5):1796-1806. [4]Zhang Y,Zhang L,Zhang G,et al.Osteosarcoma metastasis: prospective role of ezrin[J].Tumour Biol,2014,35(6):5055-5059. [5]Lee K,Shim JH,Kang MJ,et al.Association of BAF53 with mitotic chromosomes[J].Mol Cells,2007,24(2):288-293. [6]Lessard J,Wu JI,Ranish JA,et al.An essential switch in subunit composition of a chromatin remodeling complex during neural development[J].Neuron,2007,55(2):201-215. [7]Taulli R,Foglizzo V,Morena D,et al.Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma[J].Oncogene,2014,33(18):2354-2362. [8]Xiao S,Chang RM,Yang MY,et al.ACTL6A predicts poor prognosis of Hepatocellular carcinoma and promotes metastasis and Epithelial-mesenchymal transition[J].Hepatology,2016 ,63(4):1256-1271. [9]Lin YH,Jewell BE,Gingold J,et al.Osteosarcoma: Molecular Pathogenesis and iPSC Modeling[J].Trends Mol Med,2017,23(8):737-755. [10]Krasteva V,Buscarlet M,Diaz-Tellez A,et al.The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function[J].Blood,2012,120(24):4720-4732. [11]Lu W,Fang L,Ouyang B,et al.Actl6a protects embryonic stem cells from differentiating into primitive endoderm[J].Stem Cells,2015,33(6):1782-1793.
2017, Vol. 34 
